Answer 3–4 quick questions. You'll see whether it's free on the NIP for you, whether it's a private purchase, which product suits you, and when to get it. Based on ATAGI and the Australian Immunisation Handbook, current July 2026.
RSV vaccine advice differs a lot between pregnant women, adults, and infants. This tool covers the adult and pregnancy pathways — infant protection uses a different product (nirsevimab), see the note in the result.
Eligibility for the free NIP-funded vaccine depends on age (and whether they're Aboriginal or Torres Strait Islander).
The NIP funds the RSV vaccine for Aboriginal and Torres Strait Islander adults from age 60 (5 years earlier than the general population), reflecting higher risk of severe RSV in these communities.
The RSV vaccine (Abrysvo) is given between 28 and 36 weeks of pregnancy. This timing lets the mother's antibodies transfer to the baby, protecting them for the first 6 months after birth — the highest-risk time for RSV.
Arexvy is registered for adults aged 50–59 with medical conditions that raise their risk of severe RSV. It's not NIP-funded in this group, but a GP may recommend it. Tick anything that applies.
These don't change eligibility for NIP-funded RSV vaccine (age and ATSI status do that), but they strengthen the case for getting it. Tick any that apply, or skip.
RSV cases in Australia usually rise from April, peak in June–July, and taper by September. Ideal timing is March–April, so you're protected before the peak. Protection develops within about 2 weeks. If you missed that window, it's still worthwhile any time during the season.
Both are single-dose RSV vaccines for adults 60+. ATAGI states no brand preference in that age group — either is fine. Your GP or pharmacy will use whichever they have.
The key difference: Abrysvo is the only one approved for use in pregnancy (28–36 weeks). Arexvy is not used in pregnancy but is registered for adults 50–59 with certain risk conditions. Neither vaccine contains live virus — both are safe for immunocompromised people.
If you're 60–74 and don't fit the NIP-funded groups, the vaccine typically costs $280–$350 when purchased privately (with a script from your GP). Some pharmacies stock it and can give it on the same visit; others need to order it. Prices vary — worth ringing around.
Infants don't get an RSV vaccine — they get a monoclonal antibody called nirsevimab (Beyfortus), which provides passive protection ready-made. It's funded through state and territory programs for babies going into their first RSV season, and for high-risk infants going into their second. Ask your state health department or your maternity provider.
If mum had the RSV vaccine (Abrysvo) between 28–36 weeks of pregnancy, that also protects baby for their first 6 months — many babies won't need nirsevimab as well.